Pharma companies seek hike in drug rates under price control

Chinese API imports turn 200% costlier, making production costlier in India. Over 70% of the country’s total bulk drug requirement comes from China. These bulk drugs or active pharmaceutical ingredients (API) are used in producing medicines, including essential items like antibiotics, vitamins and folic acid.

from Healthcare/Biotech-Industry-Economic Times https://ift.tt/34ipApj
via IFTTT